logo
We can cure baldness, claim scientists

We can cure baldness, claim scientists

Telegrapha day ago

Anxiously checking in the mirror for signs of male pattern baldness may be a thing of the past, as scientists in Madrid believe they have found a way to reverse hair loss.
Researchers at the San Carlos clinic in the Spanish capital claim they were able to regrow hair on mice in almost all cases during an experimental stem cell treatment study.
The project involved giving male and female mice dihydrotestosterone, a by-product of testosterone that causes receding hair lines in men and thinning hair in women.
Once the rodents had lost all their fur, half of them were injected with stem cells taken from body fat as well as a chemical called adenosine triphosphate, which stimulates cellular growth. The other half were given a placebo.
All the male mice given the stem cell-chemical cocktail experienced hair regrowth, with around half getting back all their fur. The majority of the female mice also regrew their coats.
'Hair grew back in all of the treated male mice. In the case of the females, a lower dose was used, and the results were also somewhat worse, although still good, because 90 per cent managed to repopulate their hair,' Dr Eduardo López Bran, head of dermatology at the San Carlos, explained.
Four or five years to treatment
The scientists, whose work was published in Stem Cell Research & Therapy, say that it will still be four or five years before a drug could be available, and that the next phase of testing will involve using human patients.
Hair loss or alopecia is a common complaint in Spain, which has the highest percentage of bald men in the world at 44.5 per cent, according to a survey by Medihair, an online platform for hair loss treatments.
Dr López Bran said he had 'noticed a huge increase in inquiries seeking a solution, a truly significant growth in demand, especially among young people who, at the first signs of baldness, want to slow its progression, or even reverse those initial symptoms'.
By the age of 50, roughly 50 per cent of men will experience some form of male pattern baldness. Around 25 per cent of will spot signs of thinning or receding as early as 21.
Hair transplant surgery has become increasingly popular over the last two decades, with the number of procedures performed globally rising by 76 per cent since 2006.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

What can a £5,000 at-home laser do?
What can a £5,000 at-home laser do?

Times

timean hour ago

  • Times

What can a £5,000 at-home laser do?

With the beauty-gadget industry growing at four times the rate of the overall skincare category, with sales projected to hit $92.55 billion by 2028, it seems to be becoming the favoured option for people who want the results of a visit to the aesthetician, but prefer less invasive approaches. • This article contains affiliate links that can earn us revenue As a result the British wellness brand LYMA is doing better than ever. Founded in 2018, its initial offering was the LYMA supplement, a gold-coloured capsule containing active ingredients formulated to be bioavailable and therefore fully absorbed by the body. Despite coming at a price — around £199 for a month's supply — the pills frequently sold out and were nicknamed the 'supermodel supplement' to those in the wellness world. Unsurprisingly, LYMA loyalists were thrilled when LYMA dropped its first at-home clinic-grade laser in 2020, the launch helped LYMA receive a 40 per cent increase in turnover to £32.5 million, with US sales accounting for 70 per cent of their total revenues. Now the range includes both the original LYMA laser as well as the LYMA Laser Pro which launched in March 2024. Both use technology called low-level laser therapy (LLLT) first developed in the 1960s which was previously used to treat medical injuries such as healing tendons and rebuilding cartilage. The founder of LYMA, Lucy Goff, decided to harness this existing technology and re-engineer it for the cosmetic market, creating a portable, cordless device that could be used at home without the supervision of a doctor or a prescription*. Goff consulted geneticists, longevity scientists and surgeons and spent five years developing the laser. In contrast to some other cosmetic procedures which have to deliver micro-injury to the skin and inflict damage in order to create collagen, the LYMA lasers utilise powerful, zero-damage cold laser technology. The original iteration is a smaller, handbag-sized device that features a patented 8cm² treatment lens, primarily designed for the face. The LYMA Laser Pro can also be used on the neck and body, and has cut down the initial treatment time of 15 minutes per day to just three minutes per area of concern (such as cheeks, forehead and eye areas), or a full face in as little as 9 minutes, thanks to its larger 30cm² lens. Dr Graeme Glass, a craniofacial, aesthetic and plastic surgeon and now the director of aesthetics at LYMA, helped develop the laser and has written several medical papers on its technology. With many women losing fat through the rise of Ozempic and other weight loss alternatives, Glass recommends the LYMA laser. 'Losing weight can be associated with the loss of subcutaneous fat which can give the appearance of laxity as the face and neck structures hang on relatively loose ligaments,' he says. 'The skin loses its lustre because of loss of water content in the dermis, lack of synthesis of the protective fatty acids that condition the skin, and lack of vitamins and minerals essential for healthy skin function.' Just like the rest of our body, our skin needs energy function, which usually comes in the form of ATP (adenosine triphosphate) to help the skin stay hydrated, produce collagen and elastic, as well as promote cell renewal. Without enough ATP, the skin becomes dull and will start to sag or age at a faster rate, Glass explains. To counteract this, the LYMA laser uses the technique of low level laser therapy using near-infrared light. According to LYMA's website: 'this light triggers a natural process in your cells called photobiomodulation, which helps your skin produce ATP more efficiently. It's like charging up the skin's internal battery, so it has the energy it needs to repair and regenerate itself.' LYMA claims that over time the ATP produced through using the laser will help boost collagen and elastin production — both key for the appearance of firmer, smoother skin. The brand promises an improvement in as little as 30 days with daily use and recommends following with twice weekly sessions as maintenance. LYMA's own clinical trials involving 10 subjects showed 64.3 per cent improvement in pigmentation, a 53.8 percent improvement in wrinkles, a 42 per cent improvement in rosacea symptoms, and a 56 per cent decline in acne and blemishes.** At around £1,999 and around £4,995 respectively, the LYMA lasers are undoubtedly an expensive piece of kit, but that hasn't kept customers away. LYMA sold 47 per cent more stock than predicted in the first 24 hours of its US launch and counts a whole host of celebrities, including Sienna Miller and Gwyneth Paltrow, as loyal users. Likewise, the launch of LYMA skincare, a duo of anti-ageing serum and creams, had a waitlist of around 30,000 expectant customers. But it's the Laser Pro which is helping the brand put a stake in the ground of the $211 billion global professional beauty services market — and a pretty big stake at that. * LYMA's policy outlines if you have a recurring or previously diagnosed health condition that concerns you, or are taking prescription medication, upon purchase of our products you agree to seek medical advice from your GP before taking our products and/or making dietary and lifestyle changes. **Based on an independent clinical trial measured by Cutometer dual MPA 580 — a device used to measure skin elasticity and firmness by assessing the skin's ability to deform and return to its original shape, plus LYMA's own studies which can be found here.

UK vaccine chiefs suspend newly approved jab for over 65s - reports of two deaths and 21 severe reactions
UK vaccine chiefs suspend newly approved jab for over 65s - reports of two deaths and 21 severe reactions

Daily Mail​

time2 hours ago

  • Daily Mail​

UK vaccine chiefs suspend newly approved jab for over 65s - reports of two deaths and 21 severe reactions

UK vaccine chiefs have suspended a newly approved jab from being given to people aged over 65, after reports of two deaths and 21 severe reactions. The vaccine protects against the potentially fatal Chikungunya virus, which is typically found in the subtropical regions of the Americas, Africa, Southeast Asia, India, the Pacific Region and increasingly in Europe. Although the virus isn't found in the UK, Britons can become infected while overseas and fall ill when they return home. While the jab, called IXCHIQ, is approved in the UK it has yet to be rolled out, so there are no immediate safety concerns, British regulators said. The suspension follows global reports of 23 serious adverse effects in older people, including two deaths. It followed two fatalities in the French island La Réunion—in the Indian Ocean—where a vaccination campaign is underway following a recent Chikungunya outbreak. One death involved an 84-year-old man who developed encephalitis—a swelling of the brain—after having an adverse reaction to the vaccine. The other was a 77-year-old man living with Parkinson's disease who reportedly began finding swallowing increasingly difficult after the jab. This is believed to have triggered aspiration pneumonia, a serious infection caused by food, saliva and/or vomit entering the lungs rather than the stomach. The European Medicines Agency, who are reviewing the chikungunya vaccine following the reports, has not yet revealed the time between the dead men receiving the jabs and their deaths. There are no changes in the recommendations for vaccination with IXCHIQ for people aged between 18 and 64. The vaccine is currently not approved for use in individuals with a weakened immune system as a result of disease or medical therapy. The decision by the Commission on Human Medicines (CHM) is a precautionary measure until a further safety review has been concluded. The Medicines and Healthcare products Regulatory Agency (MHRA) is working with the vaccine manufacturer Valneva. The majority of people infected with Chikungunya develop a sudden fever and severe pain in multiple joints. Other symptoms may include headache, muscle pain, joint swelling, or rash. The virus is spread to humans by bites from infected mosquitoes, but cannot be passed from person-to-person. Symptoms typically resolve within 7 to 10 days, and most patients make a full recovery. However, in some cases the joint pain and arthritis may persist for several months or even years. Occasional cases of eye, neurological and heart complications have been reported, as well as gastrointestinal complaints. A small number of people may develop a severe version of the disease, which can lead to multiple organ failure and death. Severe symptoms and deaths are rare and usually occur in young babies or elderly people with coexisting health problems. There is no specific antiviral treatment for Chikungunya but medications (such as paracetamol) for fever and pain can be used to alleviate these symptoms. There are currently two vaccinations which protect against the virus; IXCHIQ for those aged between 18 and 64 and Vimkunya for those 12 years and older. A recent outbreak in La Réunion has seen over 47,500 cases of the virus, with 12 fatalities. In 2024 there were 112 Chikungunya cases reported in England, Wales and Northern Ireland from travellers arriving to or returning to Britain—this was nearly one-and-a-half times the level recorded in the previous year.

'It's comfortable and cosy': why working from bed is key to this agent's success
'It's comfortable and cosy': why working from bed is key to this agent's success

TTG

time3 hours ago

  • TTG

'It's comfortable and cosy': why working from bed is key to this agent's success

A travel agency owner has called for more compassion for homeworkers, arguing that she manages her company more efficiently from her house – and indeed her bed – than she ever could from an office. Paula Hansen runs World Accessible Holidays, which specialises in travel for disabled clients, entirely from her home in Wales. Like many agents, she believes a remote model enables her to maintain a healthier work-life balance and be overall more productive. But for Hansen, homeworking isn't just a perk – it's a necessity. The mother-of-one lives with fibromyalgia, a chronic disorder that causes pain in muscles and soft tissues all over the body. Other symptoms include fatigue, brain fog and sleep disturbances, all of which can significantly affect the individual's ability to work – and makes working from an office almost impossible. In 2023, 136,000 claimants of PIP (Personal Independence Payment) listed fibromyalgia as their main disabling condition. Many people in employment may also require additional sick leave and/or reduced hours, due to the severe and often volatile nature of their symptoms. But Hansen is determined not to let her fibromyalgia limit her potential as a business woman. Three years on from her diagnosis, she has developed a sturdy kit of tools for maintaining her productivity – including working from bed. 'Why shouldn't you work from bed?' Hansen tells TTG Luxury. 'It's comfortable and cosy, and you're probably working more effectively because you're relaxed.' The self-proclaimed 'bedpreneur' says that working from bed is also preferable to a desk, which tends to flare up her symptoms: 'All of the pain from my fibromyalgia is from the hips upwards, so my back will hurt if I'm sitting on a chair for too long.' Hansen's work hours are also atypical, beginning at around 10am and ending at nearly midnight. 'My pain levels are highest in the morning, so I'll do some hours after 10am, and then if I'm tired, I'll go and have a sleep, and then resume work when I wake up,' she explains. 'So it is more like a nine to 11 schedule, with lots of sleep breaks in between.' She also uses meditation and ice packs, along with painkillers when necessary, to further alleviate her symptoms. 'Why shouldn't you work from bed? It's comfortable and cosy' As well as helping her to manage pain more effectively, working from home has also been hugely beneficial for Hansen's concentration. Without the usual office disruptions, she says she can focus for longer and thus, complete tasks faster. This lack of distractions can be especially valuable for people with fibromyalgia, 80% of whom will experience issues with memory and attention. While Hansen's condition has undoubtedly made work more challenging, it has also instilled in her a great deal of empathy for her clients. The Cardiff native knows all too well the obstacles of travelling with mobility issues; as well as causing extreme tiredness, her fibromyalgia prevents her from sitting in one position for extended periods of time, which makes driving and flying particularly difficult. Hansen also has a teenage son with cerebral palsy, a neurological condition that causes muscle weakness and impaired mobility. While Evan can walk short distances, he requires a wheelchair and is unable to travel without assistance. Flying can be especially 'nightmarish', says Hansen, due to the lack of consideration from other passengers boarding the plane. It's this first-hand experience of disability that has given her the determination to continue advocating for disabled travellers – even when she's in severe pain. Hansen arranges all types of trips for her clients, from city breaks and beach holidays to safaris and honeymoons. To achieve this, she partners with specialist suppliers who can provide medical equipment, adapted transport and accessible accommodation. The disability of her customers varies, but each one has a dream of travelling without barriers. For many, it's their first holiday after a serious illness or accident. The additional requirements create extra work for Hansen, but having witnessed the life-changing power of travel for individuals with disabilities, she says 'it's all worthwhile'. 'When you have a client tell you they've gotten into the sea for the first time because you've recommended a hotel with a sea track, that is much better than just someone saying, 'I've had a great holiday,'' she explains. 'It's so rewarding.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store